Literature DB >> 9557964

Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat.

L Fan1, S Iseki.   

Abstract

Vascular endothelial growth factor (VEGF) is a secreted polypeptide with specific effects on endothelial cell growth and vascular permeability. While previous studies have focused on the expression of VEGF associated with angiogenesis in tumor and embryonal tissues, little is known about the role of VEGF in normal adult tissues. In the present study, a specific antibody was used to study the immunohistochemical localization of VEGF in the entire body of normal adult rats. Intense to moderate immunoreactivities for VEGF were detected in some endocrine cell types, namely, the parafollicular cell of thyroid gland, B cell of endocrine pancreas, N cell of adrenal medulla and a minority of the thyrotrophs of the pituitary gland. A certain exocrine cell type, i.e., the surface mucous cell of stomach, was also immunoreactive for VEGF. At the ultrastructural level, VEGF immunoreactivity was localized exclusively in the secretory granules of all immunopositive endocrine and exocrine cells examined. The present study provided immunohistochemical evidence for the occurrence of VEGF in subsets of endocrine and exocrine cells of normal adult rats, suggesting that these secretory cells regulate local vascular permeability through a paracrine action of VEGF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557964     DOI: 10.1679/aohc.61.17

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  14 in total

Review 1.  Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.

Authors:  Alessandro Granito; Sara Marinelli; Giulia Negrini; Saverio Menetti; Francesca Benevento; Luigi Bolondi
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

Review 2.  Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.

Authors:  Manuela Schmidinger; Romano Danesi
Journal:  Oncologist       Date:  2017-11-16

3.  Angiopoietins are expressed in the normal rat pituitary gland.

Authors:  Sukriti Nag; Nima Nourhaghighi; Roopa Venugopalan; Sylvia L Asa; Duncan J Stewart
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 4.  VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs.

Authors:  Yihai Cao
Journal:  Nat Rev Endocrinol       Date:  2014-07-22       Impact factor: 43.330

5.  Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas.

Authors:  Kyongsong Kim; Daizo Yoshida; Akira Teramoto
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

6.  Trehalose 6,6'-dimycolate (Cord factor) enhances neovascularization through vascular endothelial growth factor production by neutrophils and macrophages.

Authors:  I Sakaguchi; N Ikeda; M Nakayama; Y Kato; I Yano; K Kaneda
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  [Side effect management of tyrosine kinase inhibitors in urology : Gastrointestinal side effects].

Authors:  V Lieb; M Rink; D Sikic; B Keck
Journal:  Urologe A       Date:  2016-06       Impact factor: 0.639

8.  Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues.

Authors:  Yunlong Yang; Yin Zhang; Ziquan Cao; Hong Ji; Xiaojuan Yang; Hideki Iwamoto; Eric Wahlberg; Toste Länne; Baocun Sun; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

9.  Vascular Endothelial Growth Factor (VEGF) Expression in Human Pituitary Adenomas and Carcinomas.

Authors:  Ricardo V. Lloyd; Bernd W. Scheithauer; Takao Kuroki; Sergio Vidal; Kalman Kovacs; Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

10.  Expression of vascular endothelial growth factor in normal pituitary cells and pituitary adenomas producing adrenocorticotropic hormone.

Authors:  T Yamamoto; Y Nishizawa; M Tsuji; Y Saitoh; H Funai; T Hirai; A Sugihara; T Tsujimura; Y Nakata; S Ishiguro; N Terada
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.